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Abstract
Purpose: To compare the effectiveness of computed tomography (CT) and magnetic resonance imaging (MRI) in 
the staging of neuroblastomas according to the International Neuroblastoma Risk Group Staging System (INRGSS).
Material and methods: In this single-centre retrospective study we identified a total of 20 patients under the age of  
18 years, who were admitted to our hospital with neuroblastoma between January 2005 and May 2018, and who had 
both CT and MRI examination. The INRGSS stages of tumours were evaluated by CT scan and MRI. Then, stages of 
tumours were described according to the INRGSS for CT and MRI, separately. The Spearman rank correlation test 
was used for statistical analysis. The p-value < 0.05 was considered as statistically significant. 
Results: The median age was 11 months, and the age range was one month to nine years. In our results; both MRI 
and CT were significant in the determination of radiological staging of NBL, p < 0.001 and p = 0.002, respectively. 
MRI was superior to CT in radiological staging. MRI was also superior for the detection of intraspinal extension, 
involvement of multiple body compartments, metastatic disease, and bone marrow infiltration. CT was more useful 
to consider the relationship between tumours and vascular structures.
Conclusions: MRI and CT have high diagnostic accuracy rates in the staging of pre-treatment neuroblastomas. MRI 
is important in pre-treatment evaluation of neuroblastomas because of the higher detection of metastases as well as 
the lack of ionising radiation. 
Key words: children, neuroblastoma, staging, computed tomography, magnetic resonance imaging.
Correspondence address: 
Dr. Fatma Ceren Sarioglu, Dokuz Eylul University School of Medicine, Department of Radiology, Division of Paediatric Radiology, Izmir, Turkey,  
phone: +905059628801, e-mail: drcerenunal@gmail.com
Authors’ contribution: 
A Study design ∙ B Data collection ∙ C Statistical analysis ∙ D Data interpretation ∙ E Manuscript preparation ∙ F Literature search ∙ G Funds collection
Introduction
Neuroblastoma (NBL) is the most common solid, extrac-
ranial malignant tumour in children, accounting for 8% to 
10% of all childhood cancers and up to 15% of all paediat-
ric cancer fatalities [1-3]. It is derived from primitive neu-
ral crest cells that would normally form the sympathetic 
nervous system [4]. The most common site of NBL is the 
adrenal gland (48%), paraspinal ganglia in the retroper-
itoneum (25%), chest (16%), neck (3%), and pelvis (3%) 
[5]. The clinical presentation of NBLs varies based on the 
extent of disease and primary tumour location.
Imaging plays an essential role in the optimal assess-
ment of the location and local extension of the primary tu-
mour, surgical planning, follow-up of residual tumour, and 
the detection of relapse. Also, metastatic disease is evalu-
ated by multimodality imaging procedures. The treatment 
planning and outcomes of NBLs are dependent on both the 
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stage and the risk group of disease. The stage of tumour is 
determined according to the International Neuroblastoma 
Staging System (INSS), which is designed according to the 
postoperative findings as well as the radiological findings, 
lymph node involvement, and bone marrow involvement 
(Table 1) [6]. Because INSS is not suitable for the preop-
erative staging, in 2009, the International Neuroblastoma 
Risk Group (INRG) task force proposed a new staging 
system for NBL, is called with the INRG Staging System 
(INRGSS), based on their radiological findings (Table 2) 
[7]. The main radiological points, named “image-defined 
risk factors (IDRFs)”, were developed for the INRGSS 
with the confirmation of surgical findings (Table 3) [7]. 
The IDRFs vary depending on the primary tumour loca-
tion; nevertheless, encasement of large vessels, intraspinal 
extension, airway compression, contiguous organ infiltra-
tion, and involvement of the multibody compartment are 
the main criteria that should be evaluated by computed 
tomography (CT) or magnetic resonance imaging (MRI) 
for the surgical planning. Ultrasound and scintigraphic 
techniques were inadequate for determination of local ex-
tension. CT and MRI are more useful techniques to deter-
mine the factors that affect the surgical planning.
There have been several studies about the imaging 
techniques for primary, relapsed, or residual tumour im-
aging [8-10]. However, to our knowledge, there has been 
no report on the assessment of the effectiveness of preop-
erative CT scanning and MRI in the preoperative radio-
logical staging of NBL. The aim of this study is to compare 
the effectiveness of CT scanning and MRI in the staging 
of NBLs according to the INRGSS.
Material and methods
Study population
The local institutional review board approved this retro-
spective study and waived informed consent. From Jan-
uary 2005 to March 2018, 76 paediatric patients of NBL 
were registered in the paediatric oncology department at 
our institution. Fifty were excluded because no preopera-
tive or pretreatment CT scans (n = 20), no MRIs (n = 26), 
and no contrast-enhanced CT scans (n = 4) were avail-
able for review. An additional six patients were exclud-
ed because the quality of their images was not sufficient 
for the staging analysis. The study included 20 patients 
with NBL, who had both contrast-enhanced CT scan and 
MRI at diagnosis. The patient group consisted of children 
without any treatment before the initial CT scan and MRI. 
The maximum interval between the CT scan and MRI was 
21 days. All of the patients had INSS stages determined 
based on a combination of postoperative, radiological, 
metaiodobenzylguanidine (MIBG) scintigraphy, histo-
pathological, and laboratory findings. 
Imaging protocol
Computed tomography examinations were performed 
using a multi-detector CT scanner (Brilliance 64 Philips; 
Philips Medical Systems©, Eindhoven, The Netherlands). 
The routine scanning parameters for abdomen were voltage 
80-120 kVp, current 120 mA, and slice thickness 2 mm. The 
chest CT scanning parameters were voltage 80-100 kVp, 
current 120 mA, and slice thickness 2 mm. Non-ionic 
contrast material was used. The images were performed 
after the administration of 2 cc/kg of 350 mgI/ml iodised 
non-ionic venous contrast material by an automatic injec-
tor at a rate of 3 ml/s. Axial slices, and coronal and sagittal 
reformatted images were obtained. 
The images were acquired using a 1.5 T MRI sys-
tem (Gyroscan Achieva, release 8.1; Philips Medical Sys-
tems). The abdominal MRI protocol included coronal 
and axial T1-weighted turbo spin-echo (TSE) images (TR, 
5.9 ms; TE, 2.3 ms; NEX, 4; flip angle, 65; section thickness, 
0.8 mm; intersection spacing, 0.6 mm; matrix size, 416 × 416, 
Table 1. INSS classifications [6]
Stage Definition
1 Localised tumour with complete gross excision; ipsilateral 
lymph nodes negative for tumour unless attached to and 
removed with the primary tumour
2 Localised tumour with incomplete gross excision, or localised 
tumour with nonadherent ipsilateral lymph nodes positive for 
tumour
3 Unresectable unilateral tumour infiltrating across the midline 
with or without regional lymph nodes positive for tumour; 
localised unilateral tumour with contralateral regional lymph 
nodes positive for tumour; or midline tumour with bilateral 
unresectable infiltration or bilateral lymph nodes positive  
for tumour
4 Any primary tumour with distant metastatic dissemination 
(except stage 4S)
4S Localised primary tumour with metastatic dissemination 
limited to skin, liver, and/or bone marrow* in patients younger 
than 12 months
*Bone marrow involvement must be less than 10% at biopsy, and bone marrow must be neg-
ative on MIBG studies.
Table 2. INRGSS classifications [7]
Stage Definition
L1 Localised tumour not involving vital structures (as defined 
by image-defined risk factors) and confined to one body 
compartment
L2 Local-regional tumour with one or more image-defined risk 
factors
M Distant metastatic dissemination (except stage MS)
MS Metastatic dissemination limited to skin, liver, and/or bone 
marrow* in patients younger than 18 months
*Bone marrow involvement must be less than 10% at biopsy, and bone marrow must be neg-
ative on MIBG studies.
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field of view, 200 × 200 mm), and coronal T2-weight-
ed TSE images (TR/TE, 3495/90; flip angle, 90°; ETL, 
56; FOV, 50 × 180 cm; ST, 5 mm). The chest MR imaging 
protocol included coronal and axial T1-weighted turbo 
spin-echo (TSE) images (TR, 5.9 ms; TE, 2.3 ms; NEX, 4; 
flip angle, 65°; section thickness, 0.8 mm; intersection 
spacing, 0.6 mm; matrix size, 416 × 416, field of view, 
200 × 200 mm), coronal T2-weighted TSE images 
(TR/TE, 3495/90; flip angle, 90°; ETL, 56; FOV, 50×180 cm; 
ST, 5 mm). Additional contrast-enhanced axial and coronal 
T1-weighted images were obtained immediately after the 
injection of 0.1 mmol/kg of contrast. In case of necessity, 
sedation was applied either orally or intravenously for both 
techniques.
Some of the patients who had initial CT scans (n = 13) 
and initial MRI (n = 10) were referred from other insti-
tutions to our hospital, acquired using a technique that 
differed from ours; such as slice thickness. All of the im-
ages were archived at our Picture Archiving and Commu-
nication System. 
Image analysis and stage interpretation
The INRGSS stage of tumours was considered according 
to CT and MRI by using IDRFs, separately. The local ex-
tension of disease was evaluated considering IDRFs. The 
encasement of vessels, intraspinal extension, airway com-
pression, contiguous organ infiltration, or involvement of 
the multibody compartment was evaluated to determine 
the presence or absence of IDRFs. Encasement of a ves-
sel means that the vessel is completely or more than 50% 
surrounded by the tumour. No visible lumen for the vein 
is also considered as encased. If a tumour surrounded 
the vessels less than 50% or a visible lumen was seen in 
the vein, an IDRF was not present. However, when the 
tumour was in contact with the renal pedicle, IDRF was 
present, because renal pedicle may be risky in surgery. 
Intraspinal extension refers to invasion of more than one-
third of the spinal canal in the axial plane, the perimed-
ullary leptomeningeal spaces are not visible, or the spinal 
cord signal intensity is abnormal. If spinal foramina and 
epidural fat are invaded by the tumour in less than one-
third of spinal canal in the axial plane, the IDRF is not 
present. Airway compression is used when the short axis 
of airway is reduced due to tumour compression. Contig-
uous organ infiltration means that the margins between 
tumours and organ are absent or ill-defined. Infiltration of 
pericardium, diaphragm, duodenopancreatic block, and 
mesentery is also considered as a presence of IDRF. In-
volvement of multibody compartment refers to ipsilateral 




Ipsilateral tumour extension within two body compartments (i.e. neck and
chest, chest and abdomen, or abdomen and pelvis)
Neck Tumour encasing carotid artery, vertebral artery, and/or internal jugular vein
Tumour extending to skull base
Tumour compressing trachea
Cervicothoracic junction Tumour encasing brachial plexus roots
Tumour encasing subclavian vessels, vertebral artery, and/or carotid artery
Tumour compressing trachea
Thorax Tumour encasing aorta and/or major branches
Tumour compressing trachea and/or principal bronchi
Lower mediastinal tumour infiltrating costovertebral junction between T9
and T12 vertebral levels
Thoracoabdominal junction Tumour encasing aorta and/or vena cava
Abdomen and pelvis Tumour infiltrating porta hepatis and/or hepatoduodenal ligament
Tumour encasing branches of superior mesenteric artery at mesenteric root
Tumour encasing origin of celiac axis and/or origin of superior mesenteric artery
Tumour invading one or both renal pedicles
Tumour encasing aorta and/or vena cava
Tumour encasing iliac vessels
Pelvic tumour crossing sciatic notch
Intraspinal tumour extension Intraspinal tumour extension (whatever the location) provided that more than one-third of spinal canal in axial plane 
is invaded, the perimedullary leptomeningeal spaces are not visible, or the spinal cord signal intensity is abnormal
Infiltration of adjacent 
organs and structures
Pericardium, diaphragm, kidney, liver, duodenopancreatic block, and mesentery
Conditions that should be recorded but are not considered IDRFs are multifocal primary tumours, pleural effusion with or without malignant cells,  
and ascites with or without malignant cells.
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tumour extension within two body compartments (i.e. 
neck and chest, chest and abdomen, or abdomen and pel-
vis). Stage L1 tumours are localised tumours with the ab-
sence of IDRF. They do not involve the vital structures and 
are confined to one body compartment. Stage L2 tumours 
are local-regional tumours with the presence of one or 
more IDRFs. Stage M tumours are metastatic tumours 
that are revealed by using imaging modalities. Stage MS 
tumours are metastatic tumours in children younger than 
18 months, with dissemination to skin, liver, and bone 
marrow. 
The predicted INRGSS stages that were determined 
according to the INSS stages of the patients were calculat-
ed (INSS 1 → INRGSS L1; INSS 2, 3 → INRGSS L2; INSS 4 
→ INRGSS M; and INSS 4S → INRGSS MS) similarly in 
the study of Cohn et al. [5]. The readers recorded the pa-
tients’ INRGSS stage (stage L1, L2, M, or MS) for CT and 
MRI, separately. The correlation between predicted IN-
RGSS stages and found INRGSS stages according to the 
both CT and MRI were determined. 
All of the images were evaluated by two paediatric 
radiologists (F.C.S., M.S.) who had two- and three-years 
experience, respectively. The readers were unaware of the 
operation findings and patients’ final INSS stages. All 
patient data were hidden during the image analysis. The 
readers evaluated the CT and MR images and recorded 
the number of IDRFs and INRGSS stages of the tumours. 
The interval between the evaluation of CT scan and MRI 
was three weeks for both readers. When metastatic sites 
were detected, they were also recorded. In cases of the 
disagreement between the two radiologists, the imag-
es were re-evaluated and the final decision was reached 
by consensus. Also, a third radiologist (H.G.) who had 
20 years of experience re-analysed the imaging data, and 
the majority opinion was accepted.
Statistical analysis
Statistical analysis was performed using IBM SPSS ver. 
22.0 (IBM Corp., Armonk, NY, USA). The correlation 
between predicted INRGSS stage and INRGSS stage ac-
cording to the CT and MRI was determined with the 
Spearman-Rank correlation test. The degree of interob-
server agreement was determined for each of the analysed 
tumours by using weighted-kappa statistics. Kappa values 
normally lie between 0 and 1, with 0 indicating agreement 
purely by chance and 1 indicating perfect agreement [11]. 
Calculated kappa values were interpreted as follows; 
< 0.20, poor agreement; 0.21-0.40, fair agreement; 0.41-
0.60, moderate agreement; 0.61-0.80, good agreement; 
and 0.81-1.00, very good agreement [12]. 
Results
There were 20 patients, eight male and 12 female, aged 
one month to nine years (mean ± SD, 22.9 ± 28 months), 
in the study. The time range between preoperative CT 
and MRI was 0-21 days (mean ± SD, 5.85 ± 6.3 days). 
Tumours were located in the adrenal glands in 11 patients 
(55%), in the paravertebral region in four patients (20%), 
in the posterior mediastinum in three patients (15%), in 
the parapharyngeal region in two patients (10%). All of 
the patients had been staged according to the INSS. Eight 
patients underwent surgery, nine patients had MIBG 
scintigraphy performed. MIBG scintigraphy was not used 
for all patients because those under 12 months (9/20 pa-
tients), and especially under six months, were ineligible, 
and there was a problem concerning the provided modal-
ity (2/20 patients). According to the INSS, two patients 
were in stage 1, two patients were in stage 2, six patients 
were in stage 3, seven patients were in stage 4, and three 
patients were in stage 4S. Five of 10 patients who had met-
astatic disease and did not undergo MIBG scintigraphy 
at initial diagnosis were staged based on a combination 
of scintigraphic, radiological, and laboratory results. The 
predicted tumour stages according to INRGSS were two 
patients in L1 stage, eight patients in L2 stage, seven pa-
tients in M stage, and three patients in MS stage.
The degree of interobserver agreement was very good 
in the evaluation of the INRGSS stage with CT (k = 0.906) 
and MRI (k = 0.954). The distribution of tumour stages 
according to the INSS, the predicted tumour stages ac-
cording to the INRGSS, and the detected tumour stages 
according to the INRGSS for both modalities are sum-
marised in Table 4. There was a significant relationship 
between the predicted tumour stages and the determined 
tumour stages both on CT and MRI (p = 0.002, p < 0.001, 
respectively) (Figure 1). There was a higher correlation 
between the predicted tumour stages and the determined 
tumour stages by using MRI than CT. The correlation co-
efficiency was very strong in MRI (ρ value = 0.815) and 
strong in CT (ρ value = 0.658). There were 10 patients in 
the localised stage and 10 patients in the metastatic stage. 
Seven of 10 patients (70 %) in the localised stages were de-
tected by CT accurately. MRI demonstrated similar results 
with CT in the detection of localised stages (70%). On 
CT scanning, seven of 10 patients were in the metastatic 
stage. On the other hand, the number of metastatic dis-
eases was detected in nine of 10 patients by MRI. When 
considering the incompatible stages between predicted 
stages and detected stages by CT and MRI, there were six 
mismatches by CT and four mismatches by MRI. In 
case 3, intraspinal extension was detected solely by MRI. 
The stage was L1 according to CT and L2 according to 
MRI. In case 6, with INSS stage 1, predicted stage was L1 
and detected stage was L2 according to both modalities, 
and renal pedicle invasion was present; however, there was 
no residual tumour after surgery. In case 7, liver metasta-
ses were not seen on CT, whereas they were detected on 
MRI (Figure 2). In case 8, bone metastasis was not detect-
ed by CT; however, it was revealed by MRI (Figure 3). In 
case 10, the stage was M due to the humerus metastasis 
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Table 4. The distribution of tumour stages according to the INSS, the predicted tumour stages according to the INRGSS and the detected tumour stages 
according to the INRGSS























1 Adrenal 4 M M M 1 1 Bone Bone (multiple)
2 Retropharyngeal 2 L2 L2 L2 3 3 - -
3 Paravertebral 2 L2 L1 L2 0 1 - -
4 Adrenal 4 M M M 5 5 Bone Bone
5 Adrenal 4S MS MS MS 0 0 Liver Liver
6 Adrenal 1 L1 L2 L2 0 0 - -
7 Paravertebral 4S MS L2 MS 5 4 ND Liver
8 Adrenal 4 M L2 M 3 2 ND Bone
9 Adrenal 1 L1 L1 L1 0 0 - -
10 Adrenal 4 M L1 L1 0 0 ND ND
11 Adrenal 4 M M M 4 2 Bone Bone (multiple)
12 Posterior 
mediastinal 
3 L2 L2 L1 1 0 - -
13 Paravertebral 3 L2 L2 L2 7 5 - -
14 Adrenal 3 L2 L2 L2 6 6 - -




16 Paravertebral 3 L2 L2 L2 2 2 -
17 Adrenal 4 M M M 4 4 Bone Bone
18 Posterior 
mediastinal
3 L2 L1 L1 0 0 - -
19 Paravertebral 3 L2 L2 L2 2 2 - -
20 Parapharyngeal 4S MS MS MS 2 2 Liver Liver
INSS – International Neuroblastoma Staging System, INRGSS – International Neuroblastoma Risk Group Staging System, CT – Computed Tomography, MRI – Magnetic Resonance Imaging, 
ND – Not detected.
Figure 1. A 2-year-old male with neuroblastoma. Contrast-enhanced axial CT scan (A) and T2-weighted axial image on MRI (B) showed the posterior 
mediastinal mass. Aortic encasement (white arrow) and intraspinal extension were seen (black arrow)
A B
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that was revealed in MIBG scintigraphy. However, CT or 
MRI was not available for the humerus. In case 12, pos-
terior mediastinal NBL with subclavian vascular encase-
ment was detected by CT. The stage was L2 in CT and L1 
in MRI. Case 18, whose expected INRGSS stage was L2, 
had posterior mediastinal mass between T2-T6 vertebral 
bodies. The detected stage was L1 for both modalities. 
There was no intraspinal extension, airway involvement, 
or vascular encasement. 
The number of detected IDRFs was 59 and 57 using 
CT and MRI, respectively. There was a significant correla-
tion between the determination of IDRFs by CT and MRI 
(p < 0.001, ρ value = 0.938) The detected IDRFs according 
to the both CT and MRI are summarised in Table 5. Vas-
cular encasement was more detectable in CT; however, 
MRI was more useful in the determination of intraspinal 
extension and multiple body compartments. The results of 
CT and MRI in detecting airway involvement were simi-
lar. Furthermore, MRI detected a greater number of bone 
metastasis.
Discussion
Our results suggest that MRI was better than CT in de-
termining the staging of the NBL according to INRGSS. 
MRI detected a greater number of intraspinal extensions, 
Figure 2. A 4-month-old girl with paravertebral neuroblastoma. A) T2-weighted axial image showed that multiple metastatic lesions in liver. B) On con-
trast-enhanced axial CT scan, they were not demonstrated
A B
Figure 3. A 1-month-old girl with neuroblastoma in the adrenal gland. A) Contrast-enhanced T1-weighted axial image showed metastatic lesion in the 
right iliac wing (arrow). B) The metastatic iliac bone lesion could not be seen on contrast-enhanced axial CT scan
A B













CT 38 2 2 13 4 59
MRI 33 4 2 13 5 57
IDRF – Image-defined risk factors, CT – Computed Tomography; MRI: Magnetic Resonance Imaging.
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involvement of multiple body compartments, and bone 
metastases. Moreover, MRI showed the liver metastasis, 
which was not demonstrated by CT. CT was more useful 
in detecting vascular encasement.
The current staging procedures of NBL consist of CT 
or MRI for extension of tumour, bone scintigraphy or 
MIBG scintigraphy for skeletal metastases, and bone mar-
row aspiration and biopsy for marrow disease [3,13,14]. 
MIBG scintigraphy is not available for all patients due to 
some disadvantages, such as renal insufficiency. Although 
CT and MRI have long been used for imaging NBL, there 
has been no consensus about using CT or MRI in preoper-
ative and surveillance imaging of NBL [15,16]. The choice 
of imaging modalities generally depends on clinicians’ and 
radiologists’ preference as well as the institutional availa-
bility [15]. CT is a rapid imaging method; by extension it 
enables sufficient data without anaesthesia [16]. Addition-
ally, it shows the calcification in tumours. However, CT 
has ionising radiation, and children have a higher inherent 
sensitivity than adults to the negative effects of ionising ra-
diation [16]. Compared with CT, MRI offers the advantag-
es of higher contrast resolution, multiplanar acquisitions, 
and the lack of ionising radiation. In addition, an intra-
venous iodine-based contrast agent is required to provide 
soft tissue contrast with CT, whereas soft tissue contrast 
can be obtained without contrast material with MRI [14, 
17]. However, it requires anaesthesia because of the long 
acquisition time in the paediatric age group. 
There have been a few reports concerning surveillance 
imaging for NBL [10, 16, 18]. MRI and a combination of 
MRI and MIBG scintigraphy are the preferred methods 
for surveillance imaging [16, 18]. In a prospective cohort 
study by Siegel et al. [19], the accuracies of staging of CT, 
MRI, and bone scintigraphy were compared in patients 
with NBL. They found that CT and MR had statistical-
ly similar but had poor performance for local tumour 
staging. However, they assessed the images according 
to the INSS, not the evaluated IDRFs. In our study, the 
correlation between predicted stages and detected stages 
was higher in MRI than in CT (MRI ρ value = 0.815 and 
p < 0.001; CT ρ value = 0.658 and p = 0.002). 
Imaging is essential to define the resectability of the 
primary tumour and to ascertain the presence or absence 
of metastatic disease. The INSS takes into account post-
operative findings in staging, whereas INRGSS stratifies 
patients before surgical intervention based on IDRFs [7]. 
IDRFs play an important role in determining a treatment 
approach. It is crucial for the surgeon to know the extent 
of the tumour in detail before the operation. Although 
IDRFs are not required for staging patients with metastat-
ic disease, the IDRF status of the primary tumour should 
be evaluated in all patients, including patients with met-
astatic disease, so that the impact of IDRFs on outcome 
as well as the surgical resection can be prospectively eval-
uated in all patients [7]. IDRFs should be evaluated by 
CT or MRI with multiplanar techniques. Results of a me-
ta-analysis showed that CT is superior to the evaluation 
of vascular involvement [20]. MRI is more accurate than 
CT for the analysis of spinal canal extension [3,21]. In 
our study, there was a significant correlation in detect-
ing of IDRFs between CT and MRI (ρ value = 0.938 and 
p < 0.001). The vascular encasement was more detecta-
ble in CT. On the other hand, intraspinal extension was 
more discernible in MRI. The findings were compatible 
with the literature. The choice of the imaging technique 
can be made according to the primary tumour location. 
For example, CT may be preferred for the surrenal NBL 
to evaluate the vascular encasement. NBLs in the para-
vertebral region can be considered by MRI to assess the 
intraspinal extension [22].
Bone metastases and bone marrow infiltration are 
common involvement areas in NBLs. Although MIBG 
scintigraphy is the gold standard method to detect bone 
marrow involvement or metastatic bone disease, CT and 
MRI are also utilised in the evaluation of bones [3,23]. In 
particular, MRI is the most sensitive technique in deter-
mining bone metastasis due to its ability to show signal 
changes in fatty bone marrow [24]. CT is also useful in 
demonstrating bone metastasis, especially in the presence 
of pathological fracture or height loss. The presence of 
a single or multiple metastases in bones does not change 
the M-stage of the disease. However, it is essential to know 
the exact location of bone metastases in treatment plan-
ning and follow-up of the disease. It has been suggested 
that MRI is superior to CT in the evaluation of distant 
spread to bone or bone marrow [19]. In our study, CT 
was insufficient to detect bone metastasis in one of seven 
patients (case 8) whose bone metastasis was confirmed 
with MIBG scintigraphy. In two patients (case 1 and 11), 
CT was able to detect fewer bone metastases. 
The other metastatic area of NBL is the liver. NBL is 
the most common cause of metastatic liver disease in the 
paediatric age group [25]. Four of 20 patients had liver 
metastases in our study. All of the liver metastases were 
detected by both techniques except in one patient (case 7), 
who had early portal venous phase image. These metasta-
ses could not be demonstrated in CT, which may be relat-
ed to the phase of the contrast agent. 
Although imaging at the initial stage of NBL is very 
important, surgical outcomes influence the staging. Even 
if IDRFs are negative, tumour resection may vary accord-
ing to intraoperative conditions. It means that not all L1 
stage disease can always be resected completely, and L2 
stage may sometimes be resected completely. In our study, 
two patients, case 6 and case 18, were in predicted IN-
RGSS stage L1 and L2, however, their detected stages for 
both modalities were L2 and L1, respectively. 
Our study had several limitations. The retrospective 
study design was a major limitation of the present study. 
There were no available standard CT and MRI protocols 
because some CT scans and MRIs were performed at oth-
er institutions. Nonetheless, all of the images were evalu-
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ated by two paediatric radiologists and compatibility was 
very good. Our patient population was small. Although 
we had a great patient population with NBL, there was 
a small group who had both CT and MRI pretreatment 
due to starting treatment immediately after diagnosis. 
Also, MIBG scintigraphy was not available for all patients, 
so some of the patients’ INSS stages were considered ac-
cording to the clinical and imaging findings. 
Conclusions
Although there is no consensus about the optimal imag-
ing modality for assessment of pretreatment staging of 
NBL, MRI is superior to CT in determining the stage of 
NBL in our study. MRI demonstrates a greater number 
of intraspinal extensions, involvement of multiple body 
compartments, and bone metastases. CT is more use-
ful in detecting vascular encasement. CT and MRI have 
some advantages and disadvantages. Further studies are 
required to answer which modality should be preferred 
for the staging of NBL.
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